Resources /

MARS Bar

Application note showcasing Column-Free CD3/CD28+ T cell Isolation using 50nm Superparamagentic Beads on MARS® Bar

T cell Isolation using CD3/CD28 microbeads

AACR 2024 poster introducing A new Automated MARS Platform for Rapid Manufacturing of CAR-T Cells by Applied Cells

AACR 2024: A Novel Automated Platform for Rapid Manufacturing of CAR-T Cells

Application note showcasing Column-Free Monocyte Isolation using 50nm Superparamagentic Beads on MARS® Bar

Column-Free CD14+ Monocyte Isolation using 50nm Superparamagentic Beads on MARS® Bar

Application note showcasing Column-Free T cell Isolation using 50nm Superparamagentic Beads on MARS® Bar

Column-Free T cell Isolation using 50nm Superparamagentic Beads on MARS® Bar

Improving cell isolation for advanced Stem Cell therapy development

Brochure summarising benefits of CD138+ Plasma Cell Isolation for Multiple Myeloma Clinical Research with MARS Platform

Redefining CD138+ Plasma Cell Isolation for Multiple Myeloma Clinical Research

Application note highlighting benefits of CD34+ Cell Isolation from Cord Blood Mononuclear Cells (MNC) from Applied Cells MARS Bar

CD34+ Cell Isolation from Cord Blood MNC

Application note highlighting CD138+ Plasma Cell Enrichment directly from Bone Marrow with MARS platform

CD138+ Plasma Cell Enrichment directly from Bone Marrow

Poster with overview of MARS® BAR, Applied Cells magnetic cell isolation technology was presented at the ASGCT Annual Meeting.

ASGCT 2023: Simple magnetic cell separation for both autologous and allogenic cell therapy development

ISCT2023 poster showcasing simple magnetic cell separation enabled by MARS Bar for both autologous and allogenic cell therapy development.

Simple magnetic cell separation enabled by an automated, closed system for both autologous and allogenic cell therapy development

Applied Cells, Inc., was founded to create revolutionary solutions to complete the workflow of cell separation and enrichment.

Products

Technology

Applications

Company